CS logo
small CS logo
Neurology Center of New England

Foxboro, Massachusetts, United States
Neurologist in Foxborough, Massachusetts
9 Payson Rd, Foxborough, MA 02035

About Neurology Center of New England


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
EMD Serono Research & Development Institute, Inc.
3
Hoffmann-La Roche
3
ACADIA Pharmaceuticals Inc.
1
Amgen
1
Celgene
1
Global Kinetics Corporation
1
Mallinckrodt
1
Neurology Center of New England P.C.
1
Pfizer
1
Total Rows: 9

Clinical Trials at Neurology Center of New England


During the past decade, Neurology Center of New England conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100331133114400000000000000Started TrialsCompleted Trails20152016201720182019202020210246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Observational Registry of Acthar Gel for Participants With Multiple Sclerosis Relapse
2015-11-24
2019-05-09
Completed
160
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
2017-03-24
2024-08-15
Active, not recruiting
1,239
The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study
2017-03-30
2021-03-08
Terminated
764
Retrospective Study to Determine Effect of Rebif and Tecfidera on Infections and Lymphocytes
2017-08-23
2018-05-11
Completed
34
" Treating MS Patients With Lower Extremity Spasticity Using Dysport"
2018-05-01
2020-05-01
Unknown status
30
A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)
2019-07-22
2026-11-15
Active, not recruiting
295
A Study of Suboptimally Controlled Participants Previously Taking Injectable DMDs for RMS (CLICK-MS)
2019-05-21
2026-02-21
Active, not recruiting
100
Utilization of Target Ranges to Treat Parkinson's Disease With the PKG
2019-10-15
2020-10-16
Terminated
41

Rows per page:

1–13 of 13

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Neurology Center of New England" #1 sponsor was "EMD Serono Research & Development Institute, Inc." with 3 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "ACADIA Pharmaceuticals Inc." with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Neurology Center of New England" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Ipsen" with 1 trials as a collaborator and "Mallinckrodt ARD Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Neurology Center of New England


According to Clinical.Site data, the most researched conditions in "Neurology Center of New England" are "Multiple Sclerosis" (5 trials), "Multiple Sclerosis, Relapsing-Remitting" (3 trials), "Migraine" (2 trials), "Parkinson Disease" (1 trials) and "Parkinson Disease Psychosis" (1 trials). Many other conditions were trialed in "Neurology Center of New England" in a lesser frequency.

Clinical Trials Intervention Types at Neurology Center of New England


Most popular intervention types in "Neurology Center of New England" are "Drug" (7 trials), "Biological" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cladribine Tablets" (2 trials), "Ocrelizumab" (2 trials), "Placebo" (2 trials), "Abobotulinumtoxin A" (1 trials) and "Antihistamine" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Neurology Center of New England


The vast majority of trials in "Neurology Center of New England" are 13 trials for "All" genders.

Clinical Trials Status at Neurology Center of New England


Currently, there are NaN active trials in "Neurology Center of New England". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Neurology Center of New England, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Neurology Center of New England, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status